IntelligenceOverview
NewsBriefingJournalismTesseract
ExposureReportsNeural WebPlayersGeopoliticsSignal Map
MarketsMarket SignalsPulse
Entity

UniQure

UniQure is a biotechnology company that develops gene therapies for rare diseases. It is known for its work on treatments for conditions like Huntington's disease.

Why it’s in the news: It is in the news due to a reversal by the FDA allowing it to submit its Huntington's disease treatment for approval after a previous dispute.

Explore UniQure in the interactive graph

Latest on UniQure

  • FDA Reversal On uniQure Gene Therapy Is Another Sign Of Renewed Regulatory Flexibility
  • STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval

Connections

4 entities linked to UniQure across the news graph.

Also connected to (4)
HuntingtonFDAFollowingSTAT
Open the interactive Neural Web →Intelligence Briefs